相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Aberrant Cytoplasm Localization and Protein Stability of SIRT1 is Regulated by PI3K/IGF-1R Signaling in Human Cancer Cells
Vanessa Byles et al.
International Journal of Biological Sciences (2012)
Sirtuin 1 in malignant transformation: Friend or foe?
Yujiang Fang et al.
CANCER LETTERS (2011)
The Central Sirtuin 1/p53 Pathway Is Essential for the Orexigenic Action of Ghrelin
Douglas A. Velasquez et al.
DIABETES (2011)
Histone Lysine Demethylase JARID1a Activates CLOCK-BMAL1 and Influences the Circadian Clock
Luciano DiTacchio et al.
SCIENCE (2011)
SIRT Inhibitors Induce Cell Death and p53 Acetylation through Targeting Both SIRT1 and SIRT2
Barrie Peck et al.
MOLECULAR CANCER THERAPEUTICS (2010)
SIRT1 Undergoes Alternative Splicing in a Novel Auto-Regulatory Loop with p53
Cian J. Lynch et al.
PLOS ONE (2010)
The p53 orchestra: Mdm2 and Mdmx set the tone
Mark Wade et al.
TRENDS IN CELL BIOLOGY (2010)
SIRT1: recent lessons from mouse models
Daniel Herranz et al.
NATURE REVIEWS CANCER (2010)
p53 and MDM2: Antagonists or Partners in Crime?
Christine M. Eischen et al.
CANCER CELL (2009)
Signaling to p53: Ribosomal Proteins Find Their Way
Yanping Zhang et al.
CANCER CELL (2009)
Blinded by the Light: The Growing Complexity of p53
Karen H. Vousden et al.
CELL (2009)
Modes of p53 Regulation
Jan-Philipp Kruse et al.
CELL (2009)
Role of p53 in the anti-proliferative effects of Sirt1 inhibition in prostate cancer cells
Brittney Jung-Hynes et al.
CELL CYCLE (2009)
Sirtuin inhibitors
Francisco J. Alcain et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2009)
HIC1 (Hypermethylated in Cancer 1) epigenetic silencing in tumors
Capucine Fleuriel et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
SIRT1 histone deacetylase expression is associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer
Katsuhiko Nosho et al.
MODERN PATHOLOGY (2009)
Suppression of induced pluripotent stem cell generation by the p53-p21 pathway
Hyenjong Hong et al.
NATURE (2009)
Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect
E. Lara et al.
ONCOGENE (2009)
JNK1 Phosphorylates SIRT1 and Promotes Its Enzymatic Activity
Nargis Nasrin et al.
PLOS ONE (2009)
Distinct HIC1-SIRT1-p53 Loop Deregulation in Lung Squamous Carcinoma and Adenocarcinoma Patients
Ruo-Chia Tseng et al.
NEOPLASIA (2009)
Awakening guardian angels: drugging the p53 pathway
Christopher J. Brown et al.
NATURE REVIEWS CANCER (2009)
Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator
Sonia Lain et al.
CANCER CELL (2008)
Acetylation is indispensable for p53 activation
Yi Tang et al.
CELL (2008)
SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization
Myung-Kwan Han et al.
CELL STEM CELL (2008)
Sirtuins - novel therapeutic targets to treat age-associated diseases
Siva Lavu et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition
Sanjeev Shangary et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Structure-activity studies on suramin analogues as inhibitors of NAD+-dependent histone deacetylases (Sirtuins)
Johannes Trapp et al.
CHEMMEDCHEM (2007)
Molecular basis for the inhibition of p53 by Mdmx
Grzegorz M. Popowicz et al.
CELL CYCLE (2007)
Induction of p53-dependent senescence by the MDM2 antagonist nutlin-3a in mouse cells of fibroblast origin
Alejo Efeyan et al.
CANCER RESEARCH (2007)
5-fluorouracil activation of p53 involves an MDM2-ribosomal protein interaction
Xiao-Xin Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
SIRT1 interacts with p73 and suppresses p73-dependent transcriptional activity
Jin Ming Dai et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis
Yi Tang et al.
MOLECULAR CELL (2006)
Regulation of the MDM2-p53 pathway by ribosomal protein L11 involves a post-ubiquitination mechanism
Mu-Shui Dai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction
Ke Ding et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes
B Heltweg et al.
CANCER RESEARCH (2006)
Microarray analysis of promoter methylation in lung cancers
M Fukasawa et al.
JOURNAL OF HUMAN GENETICS (2006)
Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses
WY Chen et al.
CELL (2005)
Preparation of enzymatically active recombinant class III protein deacetylases
BJ North et al.
METHODS (2005)
AMP-activated protein kinase induces a p53-dependent metabolic checkpoint
RG Jones et al.
MOLECULAR CELL (2005)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors
N Issaeva et al.
NATURE MEDICINE (2004)
Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice
HL Cheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The acetylase activity of p300 is dispensable for MDM2 stabilization
SX Zeng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Acetylation of p53 inhibits its ubiquitination by Mdm2
MY Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Mutual dependence of MDM2 and MDMX in their functional inactivation of p53
JJ Gu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening
CM Grozinger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Negative control of p53 by Sir2α promotes cell survival under stress
JY Luo et al.
CELL (2001)
hSIR2SIRT1 functions as an NAD-dependent p53 deacetylase
H Vaziri et al.
CELL (2001)
ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage
R Maya et al.
GENES & DEVELOPMENT (2001)
p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2
A Ito et al.
EMBO JOURNAL (2001)
Deacetylation of p53 modulates its effect on cell growth and apoptosis
JY Luo et al.
NATURE (2000)
MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins
E Kobet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
p53AlP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53
K Oda et al.
CELL (2000)
A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage
TT Paull et al.
CURRENT BIOLOGY (2000)
分享论文
